COM:PIERIS
Pieris Pharmaceuticals, Inc.
- Stock
Last Close
16.11
13/12 21:00
Market Cap
9.31M
Beta: -
Volume Today
51.73K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 5.37M - | 2.93M 45.35% | 5.83M 98.87% | 25.27M 333.48% | 29.10M 15.14% | 46.28M 59.03% | 29.32M 36.64% | 31.42M 7.14% | 25.90M 17.56% | 42.81M 65.28% | |
cost of revenue | |||||||||||
gross profit | 5.37M - | 2.93M 45.35% | 5.83M 98.87% | 25.27M 333.48% | 29.10M 15.14% | 46.28M 59.03% | 29.32M 36.64% | 31.42M 7.14% | 25.90M 17.56% | 42.81M 65.28% | |
selling and marketing expenses | |||||||||||
general and administrative expenses | 6.96M - | 8.37M 20.18% | 8.89M 6.25% | 17.58M 97.78% | 18.44M 4.88% | 18.44M 0.01% | 16.71M 9.37% | 16.59M 0.72% | 16.39M 1.20% | 16.85M 2.80% | |
selling general and administrative expenses | 6.96M - | 8.37M 20.18% | 8.89M 6.25% | 17.58M 97.78% | 18.44M 4.88% | 18.44M 0.01% | 16.71M 9.37% | 16.59M 0.72% | 16.39M 1.20% | 16.85M 2.80% | |
research and development expenses | 5.60M - | 8.24M 47.22% | 19.70M 138.93% | 22.29M 13.13% | 41.49M 86.18% | 55.00M 32.55% | 46.53M 15.39% | 66.66M 43.25% | 52.98M 20.51% | 41.80M 21.10% | |
other expenses | 3.00K - | 10.90K 263.26% | 119.50K 995.84% | -2.10M 1,858.98% | 1.80M 185.78% | -26K 101.44% | -3.66M 13,961.54% | -3.69M 0.79% | -8.17M 121.79% | 13.91M 270.22% | |
cost and expenses | 12.56M - | 16.61M 32.23% | 28.59M 72.09% | 39.87M 39.45% | 59.93M 50.32% | 73.44M 22.53% | 63.24M 13.88% | 79.56M 25.80% | 61.20M 23.08% | 72.57M 18.57% | |
operating expenses | 12.56M - | 16.61M 32.23% | 28.59M 72.09% | 39.87M 39.45% | 59.93M 50.32% | 73.44M 22.53% | 63.24M 13.88% | 79.56M 25.80% | 61.20M 23.08% | 72.57M 18.57% | |
interest expense | 2.65M - | 184.65K 93.04% | 2.32K 98.74% | 1.95M 83,951.72% | -3.77M 293.08% | -10.20M - | |||||
ebitda | -7.20M - | -13.67M 89.99% | -22.76M 66.49% | -14.22M 37.50% | -30.26M 112.73% | -26.12M 13.69% | -31.79M 21.74% | -48.15M 51.43% | -35.30M 26.68% | -29.76M 15.71% | |
operating income | -7.20M - | -13.68M 90.06% | -22.76M 66.35% | -14.59M 35.88% | -30.83M 111.26% | -27.16M 11.92% | -33.92M 24.91% | -51.83M 52.80% | -43.47M 16.12% | -29.76M 31.55% | |
depreciation and amortization | 366.98K - | 307.91K 16.10% | 361.38K 17.37% | 369K 2.11% | 570K 54.47% | 1.04M 82.46% | 2.13M 104.52% | 3.69M 73.25% | 8.17M 121.79% | ||
total other income expenses net | 3.00K - | 10.90K 263.26% | 119.50K 995.84% | -2.10M 1,858.98% | 3.77M 279.12% | 1.69M 55.17% | -3.15M 286.32% | 6.09M 293.74% | 10.20M 67.36% | 5.21M 48.88% | |
income before tax | -9.85M - | -13.85M 40.66% | -22.64M 63.39% | -16.54M 26.92% | -27.07M 63.60% | -25.47M 5.90% | -37.07M 45.53% | -45.74M 23.40% | -33.28M 27.24% | -24.54M 26.25% | |
income tax expense | -18 - | 203.87K 1,132,688.89% | 161.97K 20.55% | 1.10M 580.99% | -312K 128.29% | -1.71M 449.36% | 164K 109.57% | -2.37M 1,546.34% | -2.02M 14.67% | ||
net income | -9.85M - | -14.06M 42.73% | -22.80M 62.17% | -17.65M 22.60% | -26.75M 51.61% | -23.75M 11.21% | -37.23M 56.72% | -43.37M 16.48% | -31.25M 27.93% | -24.54M 21.47% | |
weighted average shs out | 13.87M - | 34.39M 147.92% | 41.71M 21.29% | 43.93M 5.32% | 53.08M 20.83% | 50.63M 4.63% | 54.48M 7.62% | 64.55M 18.48% | 74.17M 14.91% | 90.06M 21.43% | |
weighted average shs out dil | 13.87M - | 34.39M 147.92% | 41.71M 21.29% | 43.93M 5.32% | 53.08M 20.83% | 50.63M 4.63% | 54.48M 7.62% | 64.55M 18.48% | 74.17M 14.91% | 90.06M 21.43% | |
eps | -0.71 - | -0.41 42.25% | -0.55 34.15% | -0.40 27.27% | -0.50 25.00% | -0.47 6.00% | -0.68 44.68% | -0.67 1.47% | -0.42 37.31% | -0.27 35.71% | |
epsdiluted | -0.71 - | -0.41 42.25% | -0.55 34.15% | -0.40 27.27% | -0.50 25.00% | -0.47 6.00% | -0.68 44.68% | -0.67 1.47% | -0.42 37.31% | -0.27 35.71% |
All numbers in USD (except ratios and percentages)